Clinical Trial Update: Single Dose Trial of Extended Release Combination Tablet Codeine and Guaifenesin [Phase 1]

View source ↗

Summary

A Phase 1 single-dose trial of an extended-release combination tablet of codeine and guaifenesin has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cough

Drugs mentioned

• Codeine and Guaifenesin Extended Release Combination Tablet (codeine; guaifenesin)

Snippet

Sponsor: Nexgen Pharma, Inc | Conditions: Cough | Phase 1 | Status: COMPLETED